Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aeterna Zentaris (AEZS)
NASDAQ:AEZS
Holding AEZS?
Track your performance easily
AEZS Stock Chart & Stats
Day’s Range$5.48 - $6.2
52-Week Range― - ―
Previous Close$5.4
Volume7.56K
Average Volume (3M)N/A
Market Cap
$21.18M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next Earnings
Nov 07, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Aeterna Zentaris News
PremiumCompany Announcements
COSCIENS Biopharma Debuts New Name and Ticker
PremiumCompany Announcements
Aeterna Zentaris Release: A Technical Glitch?
PremiumCompany Announcements
Aeterna Zentaris Wraps Up Key Pediatric Trial
PremiumCompany Announcements
Aeterna Zentaris and Ceapro Announce Merger CompletionRisk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AEZS FAQ
What was Aeterna Zentaris’s price range in the past 12 months?
Currently, no data Available
What is Aeterna Zentaris’s market cap?
Currently, no data Available
When is Aeterna Zentaris’s upcoming earnings report date?
Aeterna Zentaris’s upcoming earnings report date is Nov 07, 2024 which is 44 days ago.
How were Aeterna Zentaris’s earnings last quarter?
Currently, no data Available
Is Aeterna Zentaris overvalued?
According to Wall Street analysts Aeterna Zentaris’s price is currently Overvalued.
Does Aeterna Zentaris pay dividends?
Aeterna Zentaris does not currently pay dividends.
What is Aeterna Zentaris’s EPS estimate?
Aeterna Zentaris’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aeterna Zentaris have?
Currently, no data Available
What happened to Aeterna Zentaris’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Aeterna Zentaris?
Currently, no hedge funds are holding shares in AEZS
---
Aeterna Zentaris Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Crowd Wisdom
Positive
Last 7 Days ▼ 1.6%
Last 30 Days ▲ 3.9%
Last 30 Days ▲ 3.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-48.66%
12-Months-Change
Fundamentals
Return on Equity
-81.71%
Trailing 12-Months
Asset Growth
-38.01%
Trailing 12-Months
Company Description
Aeterna Zentaris
Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company that is engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health. It operates through biopharmaceutical segment. AEterna Zentaris was founded on September 12, 1990 and is headquartered in Charleston, SC.
---
AEZS Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering AEZS
1 Year
1 Year Success Rate
1/4 ratings generated profit
1 Year Average Return
-34.73%
reiterated a buy rating a year ago
Copying Boobalan Pachaiyappan's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -34.73% per trade.
---